The fate of benzene-oxide

Chemico-Biological Interactions

Volumn 184, Issue 1-2, 2010, Pages 201-206

  Monks, Terrence J ^a   Butterworth, Michael ^b   Lau, Serrine S ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Benzene metabolism; Benzene oxide; Bone marrow; Hematotoxicity; Hydroquinone; Muconaldehyde; Phenol

Indexed keywords

1,2 BENZOQUINONE; 1,4 BENZOQUINONE; 6 HYDROXY 2,4 HEXADIENOIC ACID; ACETYLCYSTEINE; BENZENE; BENZENE DERIVATIVE; BENZENE EPOXIDE; BENZENE OXIDE GLUTATHIONE CONJUGATE; CATECHOL; CYTOCHROME P450; EPOXIDE HYDROLASE; GLUCURONIDE; HYDROQUINONE; HYDROQUINONE THIOL CONJUGATE; MUCONALDEHYDE; MUCONIC ACID; PHENOL; PHENYLMERCAPTURIC ACID; SORBIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BIOTRANSFORMATION; BLOOD TOXICITY; BONE MARROW TOXICITY; CATALYSIS; CHEMICAL INTERACTION; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; MOLECULAR STABILITY; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOGENESIS; RING OPENING; URINARY EXCRETION;

ALDEHYDES; ANIMALS; BENZENE; BONE MARROW; CYCLOHEXANES; GLUTATHIONE; HYDROQUINONES; MICE; PHENOL; RATS;

ANIMALIA; MUS; RATTUS;

EID: 77950627494     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.12.025     Document Type: Article

References (56)

1. Schultzen O., Naunyn B. The behavior of benzene-derived hydrocarbons in the animal organism. duBois-Reymond's Arch. Anat. Physiol. 1867, 1867:349.
2. Baumann E. Concerning the occurrence of brenzcatechin in the urine. Pflugers Arch. Physiol. 1876, 12:p69.
3. Boyland E., Levi A.A. Metabolism of polycyclic compounds: production of dihydroxydihydroanthracene from anthracene. Biochem. J. 1935, 29(12):2679-2683.
4. Young L. The metabolic conversion of naphthalene to 1:2-dihydronaphthalene-1:2-diol. Biochem. J. 1947, 41(3):417-422.
5. Boyland E., Wolf G. Metabolism of polycyclic compounds. 6. Conversion of phenanthrene into dihydroxydihydrophenanthrenes. Biochem. J. 1950, 47(1):64-69.
6. Boyland E. The biological significance of metabolism of polycyclic compounds. Biochem. Soc. Symp. 1950, 5:p4054.
7. Monks T.J., Lau S.S., Gillette J.R. Diffusion of reactive metabolites out of hepatocytes: studies with bromobenzene. J. Pharmacol. Exp. Ther. 1984, 228(2):393-399.
8. Lau S.S., Monks T.J., Greene K.E., Gillette J.R. Detection and half-life of bromobenzene-3,4-oxide in blood. Xenobiotica 1984, 14(7):539-543.
9. Lindstrom A.B., Yeowell-O'Connell K., Waidyanatha S., Golding B.T., Tornero-Velez R., Rappaport S.M. Measurement of benzene oxide in the blood of rats following administration of benzene. Carcinogenesis 1997, 18(8):1637-1641.
10. Henderson A.P., Barnes M.L., Bleasdale C., Cameron R., Clegg W., Heath S.L., Lindstrom A.B., Rappaport S.M., Waidyanatha S., Watson W.P., Golding B.T. Reactions of benzene oxide with thiols including glutathione. Chem. Res. Toxicol. 2005, 18(2):265-270.
11. 13C6]benzene. Cancer Res. 1994, 54(18):4907-4914.
12. Bleasdale C., Kennedy G., MacGregor J.O., Nieschalk J., Pearce K., Watson W.P., Golding B.T. Chemistry of muconaldehydes of possible relevance to the toxicology of benzene. Environ. Health Perspect. 1996, 104(Suppl 6):1201-1209.
13. Jaffe M. Cleavage of the benzene ring in the organism. 1. The excretion of muconic acid in the urine after ingestion of benzene. Z. Physiol. Chem. 1909, 62:p58-67.
14. 14C]phenol. Biochemistry 1953, 55:337-340.
15. Kline S.A., Robertson J.F., Grotz V.L., Goldstein B.D., Witz G. Identification of 6-hydroxy-trans,trans-2,4-hexadienoic acid, a novel ring-opened urinary metabolite of benzene. Environ. Health Perspect. 1993, 101(4):310-312.
16. Latriano L., Goldstein B.D., Witz G. Formation of muconaldehyde, an open-ring metabolite of benzene, in mouse liver microsomes: an additional pathway for toxic metabolites. Proc. Natl. Acad. Sci. U.S.A. 1986, 83(21):8356-8360.
17. Kline S.A., Xiang Q., Goldstein B.D., Witz G. Reaction of (E,E)-muconaldehyde and its aldehydic metabolites, (E,E)-6-oxohexadienoic acid and (E,E)-6-hydroxyhexa-2,4-dienal, with glutathione. Chem. Res. Toxicol. 1993, 6(4):578-583.
18. Witz G., Zhang Z., Goldstein B.D. Reactive ring-opened aldehyde metabolites in benzene hematotoxicity. Environ. Health Perspect. 1996, 104(Suppl 6):1195-1199.
19. Rivedal E., Witz G. Benzene metabolites block gap junction intercellular communication. Role in hematotoxicity and leukemia?. Chem. Biol. Interact. 2005, 153-154:257-260.
20. Rivedal E., Leithe E. The benzene metabolite trans,trans-muconaldehyde blocks gap junction intercellular communication by cross-linking connexin43. Toxicol. Appl. Pharmacol. 2008, 232(3):463-468.
21. Eastmond D.A., Smith M.T., Irons R.D. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol. Appl. Pharmacol. 1987, 91(1):85-95.
22. Subrahmanyam V.V., Doane-Setzer P., Steinmetz K.L., Ross D., Smith M.T. Phenol-induced stimulation of hydroquinone bioactivation in mouse bone marrow in vivo: possible implications in benzene myelotoxicity. Toxicology 1990, 62(1):107-116.
23. Legathe A., Hoener B.A., Tozer T.N. Pharmacokinetic interaction between benzene metabolites, phenol and hydroquinone, in B6C3F1 mice. Toxicol. Appl. Pharmacol. 1994, 124(1):131-138.
24. Ohnishi T., Yamazaki H., Iyanagi T., Nakamura T., Yamazaki I. One-electron-transfer reactions in biochemical systems. II. The reaction of free radicals formed in the enzymic oxidation. Biochim. Biophys. Acta 1969, 172(3):357-369.
25. Willson R.L. Pulse radiolysis studies of electron transfer in aqueous quinone solutions. J. Chem. Soc., Trans. Faraday Soc. 1971, 67:3020-3029.
26. Meisel D. Free energy correlation of rate constants for electron transfer between organic systems in aqueous solutions. Chem. Phys. Lett. 1975, 34:263-266.
27. Sawada Y., Iyanagi T., Yamazaki I. Relation between redox potentials and rate constants in reactions coupled with the system oxygen-superoxide. Biochemistry 1975, 14(17):3761-3764.
28. Rao D.N., Takahashi N., Mason R.P. Characterization of a glutathione conjugate of the 1,4-benzosemiquinone-free radical formed in rat hepatocytes. J. Biol. Chem. 1988, 263(34):17981-17986.
29. Rossi L., Moore G.A., Orrenius S., O'Brien P.J. Quinone toxicity in hepatocytes without oxidative stress. Arch. Biochem. Biophys. 1986, 251(1):25-35.
30. Lau S.S., Hill B.A., Highet R.J., Monks T.J. Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution. Mol. Pharmacol. 1988, 34(6):829-836.
31. Hill B.A., Kleiner H.E., Ryan E.A., Dulik D.M., Monks T.J., Lau S.S. Identification of multi-S-substituted conjugates of hydroquinone by HPLC-coulometric electrode array analysis and mass spectroscopy. Chem. Res. Toxicol. 1993, 6(4):459-469.
32. 3H]benzene by F344/N rats and B6C3F1 mice. Toxicol. Appl. Pharmacol. 1988, 94(1):128-140.
33. MacDonald T.A., Holland N.T., Skibola C., Duramad P., Smith M.T. Hypothesis: phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia. Leukemia 2001, 15(1):10-20.
34. Pezzagno G., Maestri L. The specificity of trans,trans-muconic acid as a biological indicator for low levels of environmental benzene. Indoor Built. Environ. 1997, 6:12-18.
35. Bratton S.B., Lau S.S., Monks T.J. Identification of quinol thioethers in bone marrow of hydroquinone/phenol-treated rats and mice and their potential role in benzene-mediated hematotoxicity. Chem. Res. Toxicol. 1997, 10(8):859-865.
36. Snyder C.A., Goldstein B.D., Sellakumar A., Wolman S.R., Bromberg I., Erlichman M.N., Laskin S. Hematotoxicity of inhaled benzene to Sprague-Dawley rats and AKR mice at 300ppm. J. Toxicol. Environ. Health 1978, 4:605-618.
37. Hill B.A, Davison K.L., Dulik D.M., Monks T.J., Lau S.S. Metabolism of 2-(glutathion-S-yl)hydroquinone and 2,3,5-(triglutathion-S-yl)hydroquinone in the in situ perfused rat kidney: relationship to nephrotoxicity. Toxicol. Appl. Pharmacol. 1994, 129(1):121-132.
38. Thomas D.J., Sadler A., Subrahmanyam V.V., Siegel D., Reasor M.J., Wierda D., Ross D. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells. Mol. Pharmacol. 1990, 37(2):255-262.
39. Kariya K., Lee E., Hirouchi M., Hosokawa M., Sayo H. Purification and some properties of peroxidases of rat bone marrow. Biochim. Biophys. Acta 1987, 911(1):95-101.
40. Hill B.A., Lo H.H., Monks T.J., Lau S.S. The role of gamma-glutamyl transpeptidase in hydroquinone-glutathione conjugate mediated nephrotoxicity. Adv. Exp. Med. Biol. 1991, 283:749-751.
41. Earhart R.H., Khandekar J.D., Faraggi D., Schinella R.A., Davis T.E. Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine. Invest. New Drugs 1989, 7(2-3):255-260.
42. Ikeda Y., Fujii J., Taniguchi N., Meister A. Human gamma-glutamyl transpeptidase mutants involving conserved aspartate residues and the unique cysteine residue of the light subunit. J. Biol. Chem. 1995, 270(21):12471-12475.
43. 14C]hydroquinone and the effect of gamma-glutamyl transpeptidase inhibition. Toxicol. Appl. Pharmacol. 1990, 103(1):121-132.
44. Houghton C.B., Cherian M.G. Effects of inhibition of cystathionase activity on glutathione and metallothionein levels in the adult rat. J. Biochem. Toxicol. 1991, 6(3):221-228.
45. Link D., Drebing C., Glode L.M. Cystathionase: a potential cytoplasmic marker of hematopoietic differentiation. Blut 1983, 47(1):31-39.
46. Dethmers J.K., Meister A. Glutathione export by human lymphoid cells: depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation. Proc. Natl. Acad. Sci. U.S.A. 1981, 78(12):7492-7496.
47. Dempster A.M., Snyder C.A. Short term benzene exposure provides a growth advantage for granulopoietic progenitor cells over erythroid progenitor cells. Arch. Toxicol. 1990, 64(7):539-544.
48. Niculescu R., Kalf G.F. A morphological analysis of the short-term effects of benzene on the development of the hematological cells in the bone marrow of mice and the effects of interleukin-1 alpha on the process. Arch. Toxicol. 1995, 69(3):141-148.
49. Groopman J.E., Molina J.M., Scadden D.T. Hematopoietic growth factors. Biology and clinical applications. N. Engl. J. Med. 1989, 321(21):1449-1459.
50. Irons R.D., Stillman W.S., Colagiovanni D.B., Henry V.A. Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro. Proc. Natl. Acad. Sci. U.S.A. 1992, 89(9):3691-3695.
51. Hazel B.A., O'Connor A., Niculescu R., Kalf G.F. Benzene and its metabolite, hydroquinone, induce granulocytic differentiation in myeloblasts by interacting with cellular signaling pathways activated by granulocyte colony-stimulating factor. Stem Cells 1995, 13(3):295-310.
52. Kalf G.F., O'Connor A. The effects of benzene and hydroquinone on myeloid differentiation of HL-60 promyelocytic leukemia cells. Leuk. Lymphoma 1993, 11(5-6):331-338.
53. Hazel B.A., Kalf G.F. Induction of granulocytic differentiation in myeloblasts by hydroquinone, a metabolite of benzene, involves the leukotriene D4 receptor. Recept. Signal Transduct. 1996, 6(1):1-12.
54. Bunting K.D. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 2002, 20(1):11-20.
55. Kuo M.T. Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities. Antioxid. Redox Signal 2009, 11(1):99-133.
56. Slot A.J., Wise D.D., Deeley R.G., Monks T.J., Cole S.P. Modulation of human multidrug resistance protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) transport activities by endogenous and exogenous glutathione-conjugated catechol metabolites. Drug Metab. Dispos. 2008, 36(3):552-560.